About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

EEG Objectification in Neuropsychiatry | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT01476228

EEG Objectification in Neuropsychiatry

The main objective of the study is to evaluate the use of EEG in the management and follow-up of neuropsychiatric disorders. Secondary objectives are therefore better understanding of the pathological...

Lead sponsor: Hadassah Medical Organization•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

shahar arzy, MD PhD

CONTACT

shahar.arzy@gmail.com

Sponsors

Lead Sponsor

Hadassah Medical Organization

Patients are having EEG recordings as a routine part of their clinical evaluation and diagnosis. EEG recording is harmless, has no side effects, any radiation or any mechanical or electrical influence. It is of short duration and may be done in the EEG institute or the patient's room.

Age

15 - 90 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•diagnosis of the investigated neuropsychiatric disease

Exclusion Criteria

•Other co-existing neuropsychiatric conditions
•Refusal to participate in the study

Related studies

The Mom and Infant Outcomes (MOMI) Study

NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600 · Parents, Children With Disabilities, and more

RECRUITINGPhase 3

Ketamine Augmentation of ECT in Treatment-Resistant Depression

NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression

RECRUITINGPhase 1/2

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

NCT05685368 · Race-related Stress, Depression, Anxiety, and more

RECRUITINGPhase 4

Establishing Mobile Transcranial Magnetic Stimulation

NCT06748209 · Treatment Resistant Major Depression

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 22, 2011Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment100

Start dateNov 2011

Last updatedNov 22, 2011

Condition

Personality Disorder Depression Neurodegeneration Alzheimer's Disease Epilepsy

Locations shown

HMO

Jerusalem

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 22, 2011Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions